Cargando…

Predicting the immune landscape of invasive breast carcinoma based on the novel signature of immune‐related lncRNA

BACKGROUND: The composition of the population of immune‐related long non‐coding ribonucleic acid (irlncRNA) generates a signature, irrespective of expression level, with potential value in predicting the survival status of patients with invasive breast carcinoma. METHODS: The current study uses univ...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shen, Shuang, Chen, Xin, Hu, Xiaochi, Huo, Jinlong, Luo, Libo, Zhou, Xuezhi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2021
Materias:	Bioinformatics
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8446415/ https://www.ncbi.nlm.nih.gov/pubmed/34378851 http://dx.doi.org/10.1002/cam4.4189

Ejemplares similares

A Novel Prognostic Ferroptosis-Related lncRNA Signature Associated with Immune Landscape in Invasive Breast Cancer
por: Shen, Shuang, et al.
Publicado: (2022)

A robust immune-related lncRNA signature for the prognosis of human colorectal cancer
por: Zhu, Gongmin, et al.
Publicado: (2022)

A seven-lncRNA signature for predicting Ewing’s sarcoma
por: Chen, Zhihui, et al.
Publicado: (2021)

Prognostic value and immune landscapes of immunogenic cell death-related lncRNAs in hepatocellular carcinoma
por: Chen, Wanying, et al.
Publicado: (2023)

A 7-lncRNA signature associated with the prognosis of colon adenocarcinoma
por: Fu, Xiaorui, et al.
Publicado: (2020)

Immune-related miRNA signature identifies prognosis and immune landscape in head and neck squamous cell carcinomas
por: Ma, Bo, et al.
Publicado: (2020)

Identification and validation of a ferroptosis-related lncRNA signature to robustly predict the prognosis, immune microenvironment, and immunotherapy efficiency in patients with clear cell renal cell carcinoma
por: Ju, Lincheng, et al.
Publicado: (2022)

LncRNA AC007255.1, an immune-related prognostic enhancer RNA in esophageal cancer
por: Wang, Qingqing, et al.
Publicado: (2021)

Identification of a novel four-lncRNA signature as a prognostic indicator in cirrhotic hepatocellular carcinoma
por: Ma, Linkun, et al.
Publicado: (2019)

Identification of a glycolysis-related lncRNA prognostic signature for clear cell renal cell carcinoma
por: Ma, Wei, et al.
Publicado: (2021)

Integrated analysis identifies a novel lncRNA prognostic signature associated with aerobic glycolysis and hub pathways in breast cancer
por: Li, Zheng, et al.
Publicado: (2021)

Identification of m6A methyltransferase-related lncRNA signature for predicting immunotherapy and prognosis in patients with hepatocellular carcinoma
por: Li, Lili, et al.
Publicado: (2021)

A DCS-related lncRNA signature predicts the prognosis and chemotherapeutic response of patients with gastric cancer
por: Zhang, Yang, et al.
Publicado: (2022)

Integrative analysis of dysregulated lncRNA-associated ceRNA network reveals potential lncRNA biomarkers for human hepatocellular carcinoma
por: Li, Chengyun, et al.
Publicado: (2020)

Immune-associated biomarkers for early diagnosis of Parkinson’s disease based on hematological lncRNA–mRNA co-expression
por: Lei, Kecheng, et al.
Publicado: (2020)

Circulating lncRNA UCA1 and lncRNA PGM5-AS1 act as potential diagnostic biomarkers for early-stage colorectal cancer
por: Wang, Minghui, et al.
Publicado: (2021)

Computational detection of a genome instability‐derived lncRNA signature for predicting the clinical outcome of lung adenocarcinoma
por: Guo, Chen‐Rui, et al.
Publicado: (2021)

Identification of a novel intermittent hypoxia-related prognostic lncRNA signature and the ceRNA of lncRNA GSEC/miR-873-3p/EGLN3 regulatory axis in lung adenocarcinoma
por: Liu, Peijun, et al.
Publicado: (2023)

Fifteen mRNA-lncRNA expression-based signature predicted the survival of late-staged head and neck squamous cell carcinoma
por: Ren, He, et al.
Publicado: (2020)

Development and internal validation of a nine-lncRNA prognostic signature for prediction of overall survival in colorectal cancer patients
por: Zhang, Zhiqiao, et al.
Publicado: (2018)

Construction and validation of a PANoptosis-related lncRNA signature for predicting prognosis and targeted drug response in thyroid cancer
por: Li, Ruowen, et al.
Publicado: (2023)

Immune-Related lncRNA Signature for Predicting the Immune Landscape of Head and Neck Squamous Cell Carcinoma
por: Yin, Ji, et al.
Publicado: (2021)

An Immune-Related lncRNA Signature to Predict the Biochemical Recurrence and Immune Landscape in Prostate Cancer
por: Zhang, Guian, et al.
Publicado: (2021)

Identification of hepatocellular carcinoma prognostic markers based on 10-immune gene signature
por: Zhao, Kaifei, et al.
Publicado: (2020)

Integrated analysis of two-lncRNA signature as a potential prognostic biomarker in cervical cancer: a study based on public database
por: Wu, Wenjuan, et al.
Publicado: (2019)

The transcription factor USF1 promotes glioma cell invasion and migration by activating lncRNA HAS2-AS1
por: Wang, Juntong, et al.
Publicado: (2020)

Immune cell landscape analysis reveals prognostic immune cells and its potential mechanism in squamous cell lung carcinoma
por: Wang, Yongyong, et al.
Publicado: (2020)

Immune-Related lncRNA to Construct Novel Signature and Predict the Immune Landscape of Human Hepatocellular Carcinoma
por: Hong, Weifeng, et al.
Publicado: (2020)

Development and validation of ferroptosis-related lncRNAs signature for hepatocellular carcinoma
por: Liang, Jiaying, et al.
Publicado: (2021)

Exploration of the involvement of LncRNA in HIV-associated encephalitis using bioinformatics
por: Li, Diangeng, et al.
Publicado: (2018)

The landscape of tumors-infiltrate immune cells in papillary thyroid carcinoma and its prognostic value
por: Huang, Yanyi, et al.
Publicado: (2021)

A novel long noncoding RNA (lncRNA), LINC02657(LASTR), is a prognostic biomarker associated with immune infiltrates of lung adenocarcinoma based on unsupervised cluster analysis
por: Kong, Fanming, et al.
Publicado: (2023)

Comprehensive analysis of lncRNA-associated competing endogenous RNA network in tongue squamous cell carcinoma
por: Zhang, Shusen, et al.
Publicado: (2019)

Tumor immunity landscape in non-small cell lung cancer
por: Yu, Xiaoqing, et al.
Publicado: (2018)

Immune-Related lncRNA Pairs as Prognostic Signature and Immune-Landscape Predictor in Lung Adenocarcinoma
por: Yin, Zhengrong, et al.
Publicado: (2022)

Bioinformatics profiling identifies seven immune-related risk signatures for hepatocellular carcinoma
por: Xue, Feng, et al.
Publicado: (2020)

A ferroptosis-related gene signature for overall survival prediction and immune infiltration in lung squamous cell carcinoma
por: Miao, Ti-wei, et al.
Publicado: (2022)

LncRNA RP11-551L14.4 suppresses breast cancer development by inhibiting the expression of miR-4472
por: Wang, Bin, et al.
Publicado: (2022)

The landscape and prognostic value of tumor-infiltrating immune cells in gastric cancer
por: Li, Linhai, et al.
Publicado: (2019)

Co-expression analysis and ceRNA network reveal eight novel potential lncRNA biomarkers in hepatocellular carcinoma
por: Zou, Ren-chao, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_l9qh8sm2md1jeqt7emn23k01lj